Evidence map›Paper›PMID 36601680›Full record

ReviewCNS neuroscience & therapeutics2023

When the microbiome helps the brain-current evidence.

Jovana Drljača, Nataša Milošević, Maja Milanović, Ludovico Abenavoli, Nataša Milić

Open access · goldAbstract readReview
In one paragraph

Review in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. When the microbiome helps the brain-current evidence.CNS neuroscience & therapeutics · 2023
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jovana DrljačaFaculty of Medicine, Department of Pharmacy, University of Novi Sad, Novi Sad, Serbia.ORCID 0000-0003-3785-4897
Nataša MiloševićFaculty of Medicine, Department of Pharmacy, University of Novi Sad, Novi Sad, Serbia.
Maja MilanovićFaculty of Medicine, Department of Pharmacy, University of Novi Sad, Novi Sad, Serbia.
Ludovico AbenavoliDepartment of Health Sciences, University Magna Graecia Campus "Salvatore Venuta", Catanzaro, Italy.
Nataša MilićFaculty of Medicine, Department of Pharmacy, University of Novi Sad, Novi Sad, Serbia.
University of Novi Sad · RSMagna Graecia University · IT

Funding

Provincial Secretariat for Science and Technological Development 142-451-3120/2022-01
6 · The paper itself

Abstract

The gut microbiota-brain axis has been recognized as a network of connections that provides communication between the gut microflora and both central and autonomic nervous system. The gut microbiota alteration has been targeted for therapy in various neurodegenerative and psychiatric disbalances. Psychobiotics are probiotics that contribute beneficially to the brain function and the host mental health as a result of an interaction with the commensal gut bacteria, although their mechanism of action has not been completely revealed. In this state-of-art review, the findings about the potential therapeutic effects of the psychobiotics alone or in combination with conventional medicine in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as well as in some psychiatric diseases like depression, schizophrenia, and bipolar disorder, have been summarized. The evidence of the psychobiotics therapeutic outcomes obtained in preclinical and clinical trials have been given respectively for the observed neurodegenerative and psychiatric disorders.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaNeurodegenerative DiseasesParkinson DiseaseBrainHumansalzheimer diseasegut microbiotaparkinson diseasepsychiatric diseasepsychobiotics

Identifiers

PMID36601680
PMCPMC10314113
OpenAlexW4313500713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.